Volume | 2,049,767 |
|
|||||
News | - | ||||||
Day High | 18.68 | Low High |
|||||
Day Low | 18.33 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Organon and Co | OGN | NYSE | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
18.43 | 18.33 | 18.68 | 18.55 | 18.42 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
17,612 | 2,049,767 | $ 18.55 | $ 38,019,851 | - | 10.835 - 24.79 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
19:49:38 | 20 | $ 18.40 | USD |
Organon (OGN) Options Flow Summary
Organon and Co Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
4.74B | 255.64M | - | 6.26B | 1.02B | 4.00 | 4.64 |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Organon News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical OGN Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 17.88 | 18.75 | 17.38 | 18.22 | 2,080,312 | 0.67 | 3.75% |
1 Month | 18.81 | 18.825 | 17.33 | 18.02 | 2,101,788 | -0.26 | -1.38% |
3 Months | 17.17 | 19.08 | 15.84 | 17.85 | 2,344,269 | 1.38 | 8.04% |
6 Months | 15.56 | 19.08 | 10.835 | 14.81 | 3,485,477 | 2.99 | 19.22% |
1 Year | 23.41 | 24.79 | 10.835 | 16.88 | 3,213,095 | -4.86 | -20.76% |
3 Years | 34.20 | 39.475 | 10.835 | 24.67 | 2,557,871 | -15.65 | -45.76% |
5 Years | 34.20 | 39.475 | 10.835 | 24.67 | 2,557,871 | -15.65 | -45.76% |
Organon Description
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Geographically, it derives a majority of revenue from Europe and Canada. |